repliconbas
dna
vaccin
encod
gene
canin
parvoviru
cpv
develop
clone
gene
repliconbas
dna
vaccin
vector
palpha
characterist
repliconbas
dna
vaccin
like
selfamplif
transcript
induct
apoptosi
analyz
transfect
mammalian
cell
inject
intraderm
dnalaunch
repliconbas
dna
vaccin
dog
induc
cpvspecif
humor
cell
mediat
immun
respons
viru
neutral
antibodi
lymphocyt
prolif
respons
higher
convent
cpv
dna
vaccin
commerci
cpv
vaccin
result
indic
dnalaunch
repliconbas
cpv
dna
vaccin
effect
induc
cpvspecif
humor
cellular
immun
respons
consid
effect
altern
convent
cpv
dna
vaccin
commerci
cpv
vaccin
crown
canin
parvoviru
cpv
extrem
virul
contagi
nonenvelop
singlestrand
dna
viru
belong
famili
parvovirida
genu
parvoviru
affect
dog
wolv
fox
canin
cpv
strain
evolv
felin
parvoviru
occur
three
differ
mutat
form
name
diseas
caus
viru
consid
threaten
puppi
time
wean
month
age
young
adult
dog
caus
sever
acut
leukopenia
enter
lead
death
dehydr
shock
larg
proport
case
carmichael
sever
diseas
dog
die
within
h
without
treatment
cpv
spread
dog
dog
direct
indirect
contact
fece
parrish
convent
vaccin
cpv
includ
kill
modifi
live
viru
mlv
vaccin
smithcarr
et
al
martella
et
al
kill
vaccin
requir
high
dose
antigen
per
immun
adjuv
mlv
could
excret
postvaccin
recommend
pregnanc
furthermor
newborn
gener
consid
unsuit
vaccin
recipi
due
passiv
transfer
matern
antibodi
lead
antigen
clearanc
immatur
immun
system
overcom
problem
attempt
made
develop
new
cpv
vaccin
includ
recombin
vaccin
util
baculoviru
express
system
synthet
peptid
vaccin
turiso
et
al
casal
et
al
dna
vaccin
cpv
also
investig
sever
advantag
convent
cpv
vaccin
includ
elimin
use
adjuv
effect
presenc
matern
deriv
antibodi
mda
age
anim
suppos
immun
jiang
et
al
tarpey
greenwood
gupta
et
al
patial
et
al
patel
helden
although
dna
immun
sever
advantag
limit
name
dna
vaccin
induc
longterm
uncontrol
express
transgen
possibl
integr
host
genom
possibl
induct
antidna
antibodi
macgregor
et
al
martin
et
al
beger
et
al
enhanc
dna
vaccin
immunogen
remain
challeng
larg
anim
macgregor
et
al
johnson
et
al
babiuk
et
al
increas
antigen
product
immunogen
dna
vaccin
new
strategi
develop
express
target
heterolog
antigen
control
replicon
positivestrand
rna
virus
promis
use
abil
virus
produc
larg
amount
viral
protein
infect
cell
addit
exclus
cytoplasm
replic
replicon
rna
inabl
replicon
rna
escap
transfect
cell
make
vector
biolog
safe
berglund
et
al
leitner
et
al
lundstrom
rna
repliconbas
express
vector
develop
repres
positivestrand
rna
viru
famili
name
togavirida
flavivirida
picornavirida
sever
member
alphaviru
genu
togavirida
famili
includ
sindbi
viru
xiong
et
al
herweij
et
al
hariharan
et
al
miller
et
al
saxena
et
al
gupta
et
al
semliki
forest
viru
liljestrom
garoff
berglund
et
al
zhao
et
al
venezuelan
equin
enceph
viru
davi
et
al
lee
et
al
flaviviru
genu
includ
tickborn
enceph
viru
kunjin
viru
anraku
et
al
anraku
et
al
pestivirusbvdv
coronavirushcov
curti
et
al
receiv
consider
attent
demonstr
rna
repliconbas
dna
vaccin
provid
higher
level
protect
immun
break
immunolog
toler
activ
innat
dsrnamedi
antivir
pathway
frolov
schlesing
diebold
et
al
signific
dosespar
advantag
compar
convent
dna
vaccin
miller
et
al
leitner
et
al
preliminari
studi
potenti
repliconbas
cpv
dna
vaccin
induc
cpvspecif
humor
cellular
immun
respons
analyz
immun
dog
compar
immun
respons
induc
convent
cpv
dna
vaccin
commerci
cpv
vaccin
madin
darbi
canin
kidney
mdck
cell
line
use
propag
use
viru
neutral
vn
test
prepar
cpv
antigen
cell
line
like
babi
hamster
human
embryon
use
vitro
transfect
cell
line
procur
nation
center
cell
scienc
ncc
pune
india
grown
co
dulbecco
modifi
minimum
essenti
medium
dmem
hyclon
supplement
fetal
bovin
serum
fb
hyclon
lgml
gentamicin
cpv
isol
use
studi
isol
clinic
case
india
character
cpv
type
viru
use
viru
neutral
vn
test
prepar
inactiv
cpv
antigen
convent
cpv
dna
vaccin
encod
gene
use
studi
megavacp
inact
inactiv
monoval
cpv
vaccin
indian
immunolog
india
use
commerci
cpv
vaccin
construct
repliconbas
cpv
dna
vaccin
dna
fragment
contain
full
length
gene
isol
digest
nhei
smai
restrict
endonucleas
ligat
xbai
stui
site
repliconbas
dna
vaccin
vector
palpha
gene
insert
orf
recombin
plasmid
confirm
restrict
digest
dna
sequenc
escherichia
coli
transform
recombin
plasmid
grown
lb
broth
contain
kanamycin
lgml
repliconbas
cpv
dna
vaccin
contain
cmv
promot
end
utr
nonstructur
gene
subgenom
promot
gene
polya
signal
sequenc
plasmid
isol
use
endofre
plasmid
column
qiagen
transfect
cell
use
lipofectamin
transfect
reagent
invitrogen
follow
manufactur
instruct
protein
transfect
cell
detect
sdspage
western
blot
h
posttransfect
transfect
cell
lyse
sdspage
sampl
buffer
separ
sdspage
along
protein
molecular
weight
marker
fermenta
protein
sdspage
stain
use
coomassi
brilliant
blue
stain
western
blot
protein
sdspage
transfer
onto
nitrocellulos
membran
probe
anticpv
polyclon
sera
rais
rabbit
igg
elisa
titer
bound
antibodi
detect
use
antirabbit
secondari
antibodi
conjug
alkalin
phosphatas
sigma
visual
nbtbcip
substrat
solut
ameresco
analyz
selfamplif
transcript
cell
transfect
plasmid
nonamplif
control
plasmid
delet
utr
use
recombin
plasmid
transfect
cell
use
lipofectamin
reagent
invitrogen
follow
manufactur
instruct
h
posttransfect
total
rna
isol
transfect
control
cell
use
trizol
ls
reagent
invitrogen
treat
dnase
fermenta
follow
manufactur
instruct
dnaseitr
total
rna
sampl
analyz
free
dna
contamin
pcr
use
total
rna
templat
gene
specif
primer
quantif
mrna
transcript
total
rna
revers
transcrib
cdna
use
mmlvrevers
transcriptas
fermenta
oligo
dt
primer
fermenta
realtim
pcr
cdna
mrna
kept
test
templat
cdna
mrna
kept
calibr
templat
gapdh
intern
control
cdna
dilut
use
quantit
evalu
replicas
activ
use
platinum
sybr
green
qpcr
supermixudg
invitrogen
kit
base
sybr
green
dye
follow
manufactur
protocol
primer
use
either
genespecif
primer
cpvf
cpvr
cctctatatcaccaaagtt
gapdh
primer
gapdhf
cctggagaaacctg
gapdhr
cq
valu
reaction
record
fold
differ
gene
mrna
transcript
cell
comparison
cell
transfect
determin
normal
help
gapdh
intern
control
describ
pfaffl
analyz
induct
apoptosi
cell
transfect
either
empti
vector
palpha
use
lipofectamin
reagent
invitrogen
h
posttransfect
cell
analyz
earli
onset
apoptosi
use
annexin
vfitc
apoptosi
detect
kit
sigma
follow
manufactur
instruct
transfect
cell
probe
annexin
vfitc
fluoresc
antibodi
probe
bound
phosphatidylserin
transloc
outsid
apoptot
cell
counter
stain
propidium
iodid
apoptot
cell
seen
green
fluoresc
cell
fluoresc
microscop
similarli
transfect
cell
also
analyz
apoptosi
specif
chromosom
dna
fragment
use
fluorometr
tunel
system
promega
follow
manufactur
instruct
apoptot
cell
fragment
chromosom
dna
end
label
rtdt
demonstr
beadlik
green
fluoresc
fluoresc
microscop
dna
vaccin
repliconbas
cpv
dna
vaccin
convent
cpv
dna
vaccin
empti
vector
isol
use
endofre
plasmid
giga
kit
qiagen
cat
plasmid
prepar
singl
coloni
pick
inocul
ml
luria
bertani
lb
broth
appropri
antibiot
kanamycin
lgml
ampicillin
lgml
incub
overnight
shake
five
ml
overnight
cultur
inocul
ml
lb
broth
appropri
antibiot
grown
overnight
shake
bacteri
cell
separ
centrifug
plasmid
dna
isol
use
endofre
plasmid
giga
kit
follow
manufactur
instruct
puriti
plasmid
dna
prepar
check
concentr
estim
spectrophotometr
plasmid
dna
use
immun
ethanol
precipit
resuspend
mm
nacl
concentr
mgml
dna
prepar
store
use
immun
total
healthi
mongrel
dog
age
week
screen
seroneg
vn
titer
use
studi
three
group
seroneg
dog
n
inject
intraderm
lg
either
repliconbas
cpv
dna
vaccin
convent
cpv
dna
vaccin
empti
vector
palpha
ear
pinna
one
group
n
dog
immun
intramuscularli
ml
one
dose
commerci
inactiv
cpv
vaccin
megavacp
inact
one
group
n
dog
receiv
pb
inject
kept
neg
control
group
group
dog
receiv
booster
day
postimmun
safeti
assess
vaccin
standard
health
paramet
immun
dog
includ
monitor
food
intak
bodi
weight
gener
behavior
etc
record
food
water
intak
monitor
daili
rectal
temperatur
physic
examin
includ
bodi
weight
observ
hair
coat
saliv
respir
charact
rate
eye
promin
tremor
monitor
twice
week
serum
sampl
collect
immun
dog
day
determin
cpvspecif
igg
vn
antibodi
respons
evalu
anticpv
igg
antibodi
respons
immun
dog
sera
immun
dog
analyz
elisa
follow
method
describ
earlier
use
purifi
inactiv
cpv
elisa
coat
antigen
patial
et
al
end
point
titer
determin
posit
score
sampl
absorb
absorb
healthi
dog
sera
two
time
standard
deviat
elisa
titer
defin
reciproc
highest
serum
dilut
posit
elisa
present
gmt
sem
determin
vaccin
immunogen
cpv
vaccin
group
vn
test
perform
follow
method
describ
earlier
prepar
two
fold
heatinactiv
serum
dilut
start
well
microtit
plate
triplic
mix
tcid
sera
nonvaccin
dog
also
includ
control
neutral
mdck
cell
mix
incub
three
day
observ
record
posit
neg
cpvspecif
cytopath
effect
cytopath
effect
respect
vn
antibodi
titer
calcul
reciproc
highest
serum
dilut
sera
neutral
tcid
present
gmt
sem
vn
titer
consid
protect
describ
earlier
pollock
carmichael
b
smithcarr
et
al
http
wwwveterinarypartnercom
cpvspecif
cmi
respons
immun
dog
determin
lymphocyt
prolifer
test
immunophenotyp
effector
cell
pbmc
immun
dog
day
postimmun
pbmc
isol
dog
stimul
inactiv
cpv
antigen
triplic
well
microtit
plate
along
posit
stimul
con
pha
neg
pb
control
h
stimul
stimul
cell
mix
mtt
incub
h
formazon
crystal
form
dissolv
dmso
absorb
record
nm
nm
refer
wavelength
stimul
indic
si
calcul
ratio
absorb
stimul
cell
absorb
unstimul
cell
immunophenotyp
effector
cell
pbmc
stimul
vitro
inactiv
cpv
antigen
h
stimul
cell
stain
fitc
rpe
alexa
cocktail
monoclon
antibodi
serotec
specif
cell
surfac
antigen
respect
unstimul
cell
immun
dog
also
stain
briefli
cocktail
conjug
antibodi
mix
cell
per
manufactur
instruct
incub
room
temperatur
min
stain
cell
wash
twice
pbsbsa
resuspend
pb
contain
paraformaldehyd
number
cell
duplic
sampl
collect
dog
acquir
per
cell
per
sampl
use
bd
fac
calibur
flowcytomet
bd
bioscienc
data
acquir
analyz
use
bd
cellquest
program
bd
bioscienc
fold
increas
effector
cell
popul
stimul
inactiv
purifi
cpv
antigen
unstimul
cell
calcul
induct
cpvspecif
igg
elisa
vn
titer
lymphoprolif
respons
compar
statist
analysi
use
repeat
measur
twoway
anova
follow
bonferroni
posttest
compar
vaccin
control
dog
data
present
gmt
sem
differ
group
p
consid
statist
signific
repliconbas
cpv
dna
vaccin
plasmid
encod
construct
evalu
express
protein
transfect
cell
sdspage
western
blot
data
shown
quantit
evalu
gene
transcript
cell
cell
analyz
use
real
time
pcr
cq
valu
obtain
compar
nonamplifi
control
number
mrna
transcript
cell
higher
cq
cell
cq
normal
respect
gapdh
intern
control
cq
valu
differ
found
indic
transcript
cell
fold
time
higher
transcript
cell
palphatransfect
cell
larg
number
cell
show
apoptosi
specif
green
fluoresc
mocktransfect
cell
stain
annexin
vfitc
antibodi
indic
induct
apoptosi
specif
replic
rna
replicon
fig
transfect
cell
analyz
use
fluorometr
tunel
system
beadlik
green
fluoresc
indic
dna
fragment
apoptot
cell
apoptot
bodi
found
cell
transfect
either
palpha
vector
fig
beadlik
green
fluoresc
cell
transfect
either
mocktransfect
cell
control
result
indic
induct
apoptosi
chromosom
dna
fragment
cell
due
replic
rna
replicon
fig
assess
immunogen
repliconbas
cpv
dna
vaccin
cpvspecif
humor
igg
immun
respons
immun
dog
measur
differ
interv
compar
convent
cpv
dna
vaccin
commerci
cpv
vaccin
immun
dog
standard
health
paramet
monitor
vaccin
dog
indic
advers
reaction
immun
dog
recommend
vaccin
safe
clinic
use
cpvspecif
seroconvers
observ
group
dog
receiv
differ
cpv
vaccin
dog
immun
either
repliconbas
cpv
dna
vaccin
convent
cpv
dna
vaccin
demonstr
igg
elisa
titer
day
postimmun
boost
booster
immun
titer
significantli
higher
dog
immun
repliconbas
cpv
dna
vaccin
convent
cpv
dna
vaccin
fig
empti
vector
immun
healthi
control
also
show
nonsignific
seroconvers
day
postimmun
assess
protect
efficaci
differ
cpv
vaccin
sera
collect
immun
control
dog
analyz
presenc
viru
neutral
vn
antibodi
dog
immun
repliconbas
cpv
dna
vaccin
convent
cpv
dna
vaccin
demonstr
vn
antibodi
respons
day
postimmun
howev
two
three
dog
immun
repliconbas
cpv
dna
vaccin
cross
protect
statu
vn
titer
vn
titer
group
cpv
vaccin
immun
dog
boost
booster
immun
cross
protect
statu
howev
vn
antibodi
titer
alway
maxim
repliconbas
cpv
dna
vaccin
nonsignific
seroconvers
dog
immun
empti
vector
day
postimmun
fig
cpvspecif
cmi
immun
respons
elicit
repliconbas
cpv
dna
vaccin
analyz
pbmc
vitro
stimul
inactiv
cpv
antigen
compar
elicit
convent
cpv
dna
vaccin
commerci
cpv
vaccin
cpvspecif
lymphocyt
prolif
respons
shown
fig
higher
dog
immun
either
repliconbas
cpv
dna
vaccin
commerci
cpv
vaccin
compar
dog
immun
convent
cpv
dna
vaccin
nonsignific
cpvspecif
prolif
respons
detect
dog
receiv
empti
vector
dog
receiv
pb
prolif
respons
pbmc
immun
control
dog
nonspecif
stimul
con
pha
confirm
cell
healthi
compet
prolifer
character
cpvspecif
prolifer
lymphocyt
crucial
compon
antivir
effector
stimul
lymphocyt
phenotyp
analyz
use
panel
differ
monoclon
antibodi
marker
compar
respect
unstimul
control
fig
analysi
increas
effector
cell
popul
vitro
stimul
inactiv
cpv
antigen
indic
cpvspecif
sensit
lymphocyt
signific
increas
number
fig
cpvspecif
serum
elisa
igg
antibodi
respons
immun
dog
sera
differ
group
immun
dog
collect
day
analyz
cpvspecif
elisa
igg
respons
elisa
titer
present
gmt
sem
immun
dog
group
titer
significantli
differ
control
mark
p
p
p
respect
titer
similar
superscript
letter
differ
significantli
p
fig
cpvspecif
viru
neutral
vn
antibodi
respons
immun
dog
sera
differ
group
immun
dog
collect
day
analyz
cpvspecif
vn
antibodi
respons
vn
titer
present
gmt
sem
immun
dog
group
dot
line
repres
protect
vn
titer
titer
significantli
differ
control
mark
p
p
respect
titer
similar
superscript
letter
differ
significantli
p
fig
prolif
respons
pbmc
immun
dog
vitro
stimul
vaccin
antigen
inactiv
cpv
antigen
pbmc
differ
group
immun
dog
isol
stimul
differ
nonspecif
specif
antigen
stimul
h
stimul
mtt
dye
assay
done
determin
cpvspecif
prolif
respons
group
stimul
index
si
calcul
ratio
od
antigen
stimul
cell
od
unstimul
cell
cona
pha
taken
nonspecif
stimul
data
repres
mean
sem
triplic
well
lymphocyt
dog
immun
repliconbas
cpv
dna
vaccin
compar
control
fig
enhanc
immunogen
improv
biosafeti
convent
cpv
dna
vaccin
studi
develop
repliconbas
cpv
dna
vaccin
transfect
vaccin
plasmid
transcrib
selfrepl
rna
use
cmv
promot
host
rna
polymeras
ii
insid
nucleu
transcrib
rna
transport
cytoplasm
translat
replicas
protein
express
replicas
protein
catalyz
synthesi
negativesens
transcript
act
templat
selfamplif
rna
transcript
transcript
mrna
use
subgenom
promot
sdspage
western
blot
analysi
cell
lysat
confirm
translat
protein
data
shown
reason
repliconbas
cpv
dna
vaccin
fig
immunophenotyp
lymphocyt
effector
popul
vitro
stimul
inactiv
cpv
antigen
pbmc
differ
vaccin
control
dog
isol
cultur
vitro
inactiv
cpv
antigen
duplic
h
stimul
unstimul
pbmc
stain
antidog
antibodi
number
cell
count
flowcytometri
fig
fraction
increas
effector
popul
cell
vitro
stimul
inactiv
cpv
antigen
pbmc
differ
group
immun
dog
stimul
triplic
inactiv
purifi
cpv
antigen
h
stain
antibodi
cell
count
flow
cytometri
fraction
increas
effector
cell
popul
stimul
inactiv
cpv
antigen
unstimul
cell
calcul
data
repres
mean
sem
triplic
sampl
collect
group
two
independ
experi
would
amplifi
mrna
transcript
util
selfrepl
abil
replicas
induc
apoptosi
transfect
cell
determin
selfrepl
abil
replicasebas
cpv
dna
vaccin
mrna
transcript
quantifi
use
realtim
pcr
compar
nonrepl
control
plasmid
delet
utr
made
plasmid
nonrepl
utr
posit
sens
rna
viru
report
essenti
element
initi
antisens
rna
templat
replic
richard
charl
jame
et
al
thousand
time
mrna
transcript
cell
compar
respect
nonrepl
control
indic
selfrepl
abil
repliconbas
dna
vaccin
anoth
characterist
repliconbas
dna
vaccin
induct
apoptosi
also
analyz
cell
detect
induct
apoptosi
repliconbas
cpv
dna
vaccin
specif
replic
replicon
apoptot
cell
death
analyz
empti
vector
palpha
transfect
cell
compar
cell
induct
apoptosi
detect
repliconbas
cpv
dna
vaccin
palpha
vector
confirm
annexin
v
tunel
assay
induct
apoptosi
due
format
doublestrand
rna
intermedi
produc
alphavir
replicas
rna
replic
leitner
et
al
glasgow
et
al
subsequ
activ
dsrnadepend
pathway
pkr
synthetasernas
l
provid
mechanist
explan
observ
everi
cell
transfect
vitro
repliconbas
dna
rna
undergo
apoptosi
leitner
et
al
addit
induct
apoptosi
also
confer
potenti
immunepotenti
effect
increas
safeti
clinic
use
dna
vaccin
ljungberg
et
al
vitro
character
repliconbas
cpv
dna
vaccin
immun
respons
vaccin
construct
evalu
inject
intraderm
ear
pinna
dog
cpvspecif
viru
neutral
vn
antibodi
igg
elisa
respons
detect
vaccin
dog
vn
antibodi
respons
significantli
higher
dog
immun
repliconbas
cpv
dna
vaccin
convent
cpv
dna
vaccin
commerci
cpv
vaccin
lymphoprolif
respons
cpvspecif
prime
effector
cell
significantli
higher
repliconbas
cpv
dna
vaccin
compar
convent
cpv
dna
vaccin
similar
enhanc
immun
respons
repliconbas
vaccin
convent
dna
vaccin
report
earlier
diseas
zhou
et
al
daleman
et
al
hariharan
et
al
vignuzzi
et
al
xiao
et
al
arbel
et
al
saxena
et
al
preliminari
studi
prematur
compar
convent
cpv
vaccin
repliconbas
cpv
dna
vaccin
due
limit
number
dog
per
group
studi
nonetheless
clear
induc
antibodi
cellular
immun
respons
differ
appar
repliconbas
cpv
dna
vaccin
induc
significantli
higher
respons
repliconbas
cpv
dna
vaccin
induc
dsrnamedi
apoptot
cell
death
make
vaccin
approach
effect
biolog
safe
compar
convent
dna
vaccin
respons
repliconbas
cpv
dna
vaccin
need
evalu
larg
number
dog
earli
immun
respons
durat
immun
respons
presenc
matern
deriv
antibodi
mda
consid
effect
altern
commerci
cpv
vaccin
